Naranol (W-5494A) is an antidepressant anxiolytic and antipsychotic with a tricyclic-like chemical structure which was synthesized in the late 1960s but was never marketed.
List of articles in "Drug" category - Page 90
Mezepine
Mezepine is a tricyclic antidepressant (TCA) that was never marketed.
Lortalamine
Lortalamine (LM-1404) is an antidepressant which was synthesized in the early 1980s. It acts as a potent and highly selective norepinephrine reuptake inhibitor. Lortalamine was under development for clinical use […]
Homopipramol
Homopipramol is a tricyclic antidepressant (TCA) with neuroleptic properties which was never marketed.
Mariptiline
Mariptiline (EN-207) is a tricyclic antidepressant (TCA) which was developed in the early 1980s but was never marketed.
JWH-161
JWH-161 is a cannabinoid derivative that was designed by Dr John W. Huffman’s team as a hybrid between the dibenzopyran classical cannabinoid drugs and the novel indole derivatives in an […]
Linaclotide
Linaclotide (marketed under the trade name Linzess and Constella) is an peptide agonist of guanylate cyclase 2C that is undergoing clinical trials for use in treating abdominal pain in patients […]
CI-1017
CI-1017 is a muscarinic acetylcholine receptor agonist which is selective for and is approximately equipotent at the M1 and M4 receptors with 20-30-fold lower affinity for the M2 M3 and […]
Talsaclidine
Talsaclidine (WAL-2014) is a non-selective muscarinic acetylcholine receptor agonist which acts as a full agonist at the M1 subtype and as a partial agonist at the M2 and M3 subtypes.
Mapracorat
Mapracorat (INN code names BOL-303242-X ZK 245186) is an anti-inflammatory drug belonging to the experimental class of selective glucocorticoid receptor agonists (SEGRAs). It is in clinical trials for the topical […]